KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Assets Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.40%
Dec 31, 2025 11.63%
Sep 30, 2025 12.27%
Jun 30, 2025 14.02%
Mar 31, 2025 14.72%
Dec 31, 2024 14.51%
Sep 30, 2024 11.82%
Jun 30, 2024 15.00%
Mar 31, 2024 14.13%
Dec 31, 2023 15.56%
Sep 30, 2023 11.89%
Jun 30, 2023 11.56%
Mar 31, 2023 12.89%
Dec 31, 2022 2.94%
Sep 30, 2022 2.28%
Jun 30, 2022 -0.04%
Mar 31, 2022 -2.57%
Dec 31, 2021 -2.71%
Sep 30, 2021 -1.17%
Jun 30, 2021 -4.06%
Mar 31, 2021 -4.22%
Dec 31, 2020 -7.66%
Sep 30, 2020 -6.99%
Jun 30, 2020 -6.52%
Mar 31, 2020 -7.48%
Dec 31, 2019 -8.38%
Sep 30, 2019 -8.67%
Jun 30, 2019 -7.69%
Mar 31, 2019 -5.20%
Dec 31, 2018 -2.41%
Sep 30, 2018 -2.15%
Jun 30, 2018 -1.68%
Mar 31, 2018 1.06%
Dec 31, 2017 5.03%
Sep 30, 2017 4.31%
Jun 30, 2017 4.60%
Mar 31, 2017 5.13%
Dec 31, 2016 5.49%
Sep 30, 2016 11.05%
Jun 30, 2016 12.78%
Mar 31, 2016 13.30%
Dec 31, 2015 9.58%
Sep 30, 2015 9.03%
Dec 31, 2014 12.19%
Mar 31, 2013 8.56%
Dec 31, 2012 11.07%
Sep 30, 2012 10.64%